Paper16440366
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.
Yeo W and 1 other. Hepatology, 2006. Cited by 384 papers, by iCite.
Cite this record
ConductScience Library. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Papers, record 16440366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16440366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Hepatitis B virus | Major topic |
| Hepatitis B, Chronic | Major topic |
| Alemtuzumab | |
| Antibodies, Monoclonal | |
| Antibodies, Monoclonal, Humanized | |
| Antibodies, Monoclonal, Murine-Derived | |
| Antibodies, Neoplasm | |
| DNA, Viral | |
| Hepatitis B Core Antigens | |
| Hepatitis B Surface Antigens | |
| Humans | |
| Lamivudine | |
| Recurrence | |
| Risk Factors | |
| Rituximab | |
| Virus Activation |
Source PubMed
Cited by145
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 384 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42281419 | KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA). | Clin Mol Hepatol | 2026 | https://conductscience.org/library/papers/42281419 | PubMed |
| 42230734 | True reactivation versus transient viremia: a retrospective analysis of HBV reactivation in resolved infection. | Sci Rep | 2026 | https://conductscience.org/library/papers/42230734 | PubMed |
| 42176073 | Breakthroughs in HBV-related HCC Therapy: The Unmatched Potential of Immune Checkpoint Inhibitors. | Curr Treat Options Oncol | 2026 | https://conductscience.org/library/papers/42176073 | PubMed |
| 38616853 | Hepatitis B virus reactivation in patients treated with monoclonal antibodies. | World J Virol | 2024 | https://conductscience.org/library/papers/38616853 | PubMed |
| 38570803 | Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy. | Virol J | 2024 | https://conductscience.org/library/papers/38570803 | PubMed |
| 38546893 | Investigating the correlation between prominent viruses and hematological malignancies: a literature review. | Med Oncol | 2024 | https://conductscience.org/library/papers/38546893 | PubMed |
| 38256527 | Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat? | J Clin Med | 2024 | https://conductscience.org/library/papers/38256527 | PubMed |
| 37731995 | Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/37731995 | PubMed |
| 37695530 | Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis: results from the HEBEM study. | J Neurol | 2024 | https://conductscience.org/library/papers/37695530 | PubMed |
| 36902786 | The Multiple Facets and Disorders of B Cell Functions in Hepatitis B Virus Infection. | J Clin Med | 2023 | https://conductscience.org/library/papers/36902786 | PubMed |
| 36847156 | HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma. | Cancer Med | 2023 | https://conductscience.org/library/papers/36847156 | PubMed |
| 36169566 | Occult hepatitis B virus infection in patients with chronic liver disease of different etiology in a Brazilian referral center: comparison of two different hepatitis B virus deoxyribonucleic acid amplification protocols: a cross-sectional study. | Sao Paulo Med J | 2022 | https://conductscience.org/library/papers/36169566 | PubMed |
| 36016402 | Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies. | Viruses | 2022 | https://conductscience.org/library/papers/36016402 | PubMed |
| 35763632 | Frequency of Hepatitis B Markers in Systemic Lupus Erythematosus Patients in Iran. | Asian Pac J Cancer Prev | 2022 | https://conductscience.org/library/papers/35763632 | PubMed |
| 35712098 | Long-Term Safety of Rituximab in DLBCL Patients With Hepatitis B-Related Cirrhosis: A Retrospective Case Series. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/35712098 | PubMed |
| 35566572 | Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy. | J Clin Med | 2022 | https://conductscience.org/library/papers/35566572 | PubMed |
| 35430783 | KASL clinical practice guidelines for management of chronic hepatitis B. | Clin Mol Hepatol | 2022 | https://conductscience.org/library/papers/35430783 | PubMed |
| 35071501 | Hepatitis B virus reactivation in rheumatoid arthritis. | World J Clin Cases | 2022 | https://conductscience.org/library/papers/35071501 | PubMed |
| 34621337 | COVID-19 Pandemic Impact on Cord Blood Collection for Stem Cell Use and Actual Perspectives. | Maedica (Bucur) | 2021 | https://conductscience.org/library/papers/34621337 | PubMed |
| 34277431 | HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. | Front Oncol | 2021 | https://conductscience.org/library/papers/34277431 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16440366
GET https://conductscience.org/api/papers/v1/16440366/cited_by?page=2